Intelligent Bio Solutions Inc. Selects HASTA Laboratory as Drug Testing Specialist in Australia
Intelligent Bio Solutions Inc. Selects HASTA Laboratory as Drug Testing Specialist NEW YORK, NY, March 13, 2023 — Intelligent Bio Solutions Inc. (“Intelligent Bio Solutions” or the “Company”) (Nasdaq: INBS), a life sciences company developing and delivering intelligent, non-invasive, real-time testing solutions, today announced that the Company has selected Human and Supplement Testing Australia (“HASTA”), Australia’s […]
Intelligent Bio Solutions Inc. Announces Closing of $2.55 Million Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares and Warrants
Intelligent Bio Solutions Inc. Announces Closing of $2.55 Million Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares and Warrants. NEW YORK, NY, March 8, 2023 — Intelligent Bio Solutions Inc. (“Intelligent Bio Solutions” or the “Company”) (Nasdaq: INBS), a life sciences company developing and delivering intelligent, non-invasive, real-time testing solutions, today […]
Intelligent Bio Solutions Inc. Announces Pricing of $2.2 Million Public Offering
Intelligent Bio Solutions Inc. Announces Pricing of $2.2 Million Public Offering NEW YORK, NY, March 8, 2023 — Intelligent Bio Solutions Inc. (“Intelligent Bio Solutions” or the “Company”) (Nasdaq: INBS), a life sciences company developing and delivering intelligent, non-invasive, real-time testing solutions, today announced the pricing of its previously announced underwritten public offering of 569,560 shares […]
Intelligent Bio Solutions Inc. Announces Proposed Public Offering
Intelligent Bio Solutions Inc. Announces Proposed Public Offering NEW YORK, NY, March 07, 2023 — Intelligent Bio Solutions Inc. (“Intelligent Bio Solutions” or the “Company”) (Nasdaq: INBS), a life sciences company developing and delivering intelligent, non-invasive, real-time testing solutions, today announced that it is commencing an underwritten public offering of shares of its common stock and […]
Intelligent Bio Solutions Inc. Regains Compliance with Nasdaq Listing Requirement
Intelligent Bio Solutions Inc. Regains Compliance with Nasdaq Listing Requirement NEW YORK, NY, March 1, 2023 — Intelligent Bio Solutions Inc. (“Intelligent Bio Solutions” or the “Company”) (Nasdaq: INBS), a life sciences company developing and delivering intelligent, non-invasive, real-time testing solutions, today announced that on February 27, 2023, the Company received a notification from the […]
Intelligent Bio Solutions Inc. files FDA 513(g) regulatory submission for Intelligent Fingerprinting Drug Screening Cartridge
Intelligent Bio Solutions Inc. files FDA 513(g) regulatory submission for Intelligent Fingerprinting Drug Screening Cartridge – 513(g) submission will allow Intelligent Bio Solutions Inc. to determine the most suitable FDA regulatory pathway for its Intelligent Fingerprinting Drug Screening Cartridge, as the next step in its expansion strategy into the U.S. – – Intelligent Fingerprinting Drug […]
Intelligent Bio Solutions Inc. Reports Fiscal 2023 Second Quarter Financial Results and Operational Highlights
Intelligent Bio Solutions Inc. Reports Fiscal 2023 Second Quarter Financial Results and Operational Highlights – Second quarter total revenue and government support income increased over 100% year-over-year – – Government support income increased 52% for the quarter ended December 31, 2022 compared to the prior corresponding period, mainly due to qualifying expenditures for completion of […]
Intelligent Bio Solutions Inc. Announces Leading Food Industry Logistics Provider to Implement Fingerprint Drug Testing, Replacing Urine Testing
Intelligent Bio Solutions Inc. Announces Leading Food Industry Logistics Provider to Implement Fingerprint Drug Testing, Replacing Urine Testing Boughey Distribution switches to Intelligent Fingerprinting for its faster end-to-end testing, non-invasive nature, and ability to conduct tests in-house NEW YORK, February 7, 2023 — Intelligent Bio Solutions Inc. (Nasdaq: INBS) (the “Company”), today announced that Boughey Distribution […]
Intelligent Bio Solutions Inc. Announces Global Garden Equipment Manufacturer to Introduce Intelligent Fingerprinting Drug Tests
Intelligent Bio Solutions Inc. Announces Global Garden Equipment Manufacturer to Introduce Intelligent Fingerprinting Drug Tests Gardening Supplier, Hozelock, to Roll Out Hygienic and Non-Invasive Intelligent Fingerprinting for Drug Tests to Promote Employee Safety NEW YORK, January 31, 2023 — Intelligent Bio Solutions Inc. (Nasdaq: INBS) (the “Company”), today announced that global garden equipment manufacturer Hozelock will […]
Intelligent Bio Solutions Reaches Key Milestone in Biosensor Platform Development
Intelligent Bio Solutions Reaches Key Milestone in Biosensor Platform Development NEW YORK, January 23, 2023 (GLOBE NEWSWIRE) – Intelligent Bio Solutions Inc. (“Intelligent Bio Solutions” or the “Company”) (Nasdaq: INBS), a life sciences company developing and delivering intelligent, non-invasive, real-time testing solutions, today announced it has successfully completed the review of results from Milestone 7, a […]